Sort
15,273 grants matching “antimicrobial resistance”
Colorado Emerging Infections Program
$1,735,544Kenneth A. Gershman · Colorado State Dept/Pub Hlth & Environmt · U01 · FY2007 · CI
Autophagy-Inducting Peptides and Target Identification for Treatment of Viruses
$1,732,169Beth C Levine · Washington University · U19 · FY2014 · AI
Targeted Clinical Trials for Antimicrobial Resistance
$1,730,876Vance Fowler · Duke University · N01 · FY2012 · AI
Predictive Personalized Public Health (P3H): A Novel Paradigm to Treat Infectious Disease
$1,728,465Steven J. Schiff · Yale University · R01 · FY2022 · AI
Resolving the bottleneck in antibiotic discovery
$1,726,091Kim Lewis · Northeastern University · P01 · FY2019 · AI
Structural characterization of OM proteins from Gram-negative pathogens
$1,725,277Susan Buchanan · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Systems Biology of Microbiome-mediated Resilience to Antibiotic-resistant Pathogens
$1,722,908Eric G Pamer · Sloan-Kettering Inst Can Research · U01 · FY2016 · AI
Task B05: Refinement of a Pig-Tail Macaque model of Gonococcal Infection
$1,705,236Hanne Andersen · Bioqual, Inc. · N01 · FY2018 · AI
Autophagy-Inducting Peptides and Target Identification for Treatment of Viruses
$1,703,120Beth C Levine · Washington University · U19 · FY2015 · AI
NASEM Task: EXAMINING THE LONG-TERM MEDICAL AND ECONOMIC IMPACT OF ANTIMICROBIAL RESISTANCE IN THE UNITED STATES
$1,700,000Robert Day · National Academy Of Sciences · N01 · FY2020 · OD
Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds
$1,699,924Manav Mehta · Gel4med, Inc. · R44 · FY2020 · GM
Task D03: Pre-Clinical Microbiological and Safety Studies
$1,698,255Jon Mirsalis · Sri International · N01 · FY2019 · AI
CK20-004, Chicago Prevention and Intervention Epicenter III (CPIE-III)
$1,697,292Mary Katherine Hayden · Rush University Medical Center · U54 · FY2022 · CK
Systems Biology of Microbiome-mediated Resilience to Antibiotic-resistant Pathogens
$1,697,054Eric G Pamer · Sloan-Kettering Inst Can Research · U01 · FY2017 · AI
Systems Biology of Microbiome-mediated Resilience to Antibiotic-resistant Pathogens
$1,697,054Joao Xavier · Sloan-Kettering Inst Can Research · U01 · FY2019 · AI
RT Inhibitor CSIC and Entry Inhibitor Retrocyclin RC101 as Microbicides
$1,690,071Phalguni Gupta · University Of Pittsburgh At Pittsburgh · U19 · FY2009 · AI
CK20-004, WASHINGTON UNIVERSITY & BJC EPICENTER TO PREVENT HEALTHCARE ASSOCIATED INFECTIONS & ANTIBIOTIC RESISTANCE
$1,689,958Victoria J. Fraser · Washington University · U54 · FY2022 · CK
Optimizing Lead Therapeutic Compounds Against Infectious Diseases
$1,689,686Eva Garland · Agile Sciences, Inc. · N01 · FY2015 · AI
Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies
$1,687,630Paul Clark Blainey · Broad Institute, Inc. · U19 · FY2022 · AI
OPTIMIZE - CCC - Lead Application
$1,678,874Bonnie W Ramsey · Seattle Children'S Hospital · U01 · FY2014 · HL
CK20-004, Chicago Prevention and Intervention Epicenter III (CPIE-III)
$1,678,781Mary Katherine Hayden · Rush University Medical Center · U54 · FY2023 · CK
CK20-004, Duke-UNC Prevention Epicenter Program for Protecting Patients from Infections, Antibiotics Resistance and Other Adverse Events
$1,674,336Deverick John Anderson · Duke University · U54 · FY2022 · CK
Infectious Diseases Fellowship Program
$1,663,696Christa Zerbe · National Institute Of Allergy And Infectious Diseases · ZIE · FY2021 · AI
Development of a broad spectrum teixobactin-lipopeptide hybrid for the treatment of lung infections caused by pan-drug resistant âsuperbugsâ
$1,663,595Gauri G Rao · University Of Southern California · R01 · FY2025 · AI
Translational Research to Prevent and Control Global Infectious Diseases (Translational Global Infectious Diseases Research Center, TGIR).
$1,658,162Beth Diane Kirkpatrick · University Of Vermont & St Agric College · P20 · FY2021 · GM